Ventricular fibrillation threshold; its physiological and pharmacological importance.
D000142:Acidosis, Respiratory / Q000150:complications; D000200:Action Potentials; D000628:Aminophylline / Q000494:pharmacology; D000818:Animals; D004071:Digitalis Glycosides / Q000494:pharmacology; D004285:Dogs; D004558:Electric Stimulation; D004562:Electrocardiography; D004594:Electrophysiology; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate; D006352:Heart Ventricles / Q000503:physiopathology; D000860:Hypoxia / Q000150:complications; D008012:Lidocaine / Q000494:pharmacology; D008564:Membrane Potentials; D008722:Methods; D009203:Myocardial Infarction / Q000150:complications; D011433:Propranolol / Q000494:pharmacology; D013233:Stellate Ganglion / Q000502:physiology; D014693:Ventricular Fibrillation / Q000175:diagnosis / Q000503:physiopathology*
D004071:Digitalis Glycosides; D000628:Aminophylline; D008012:Lidocaine; D011433:Propranolol